Skip to main content

Table 2 Results of surgery (no significant differences)

From: Neoadjuvant chemotherapy or primary surgery for stage III/IV ovarian cancer: contribution of diagnostic laparoscopy

Characteristic Neoadjuvant chemotherapy
(n = 26)
Primary surgery
(n = 26)
Total hysterectomy (%) 22 (85) 23 (88)
Bilateral salpingo-oophorectomy (%) 25 (96) 26 (100)
Omentectomy (%) 24 (92) 24 (92)
Rectosigmoid resection (%) 5 (19) 8 (31)
Multiple bowel resection (%) 1 (4) 1 (4)
Cytology of ascites (%)   
   Positive 8 (42) 14 (54)
   Negative 11 (58) 12 (46)
   ND 7 0
Lymphadenectomies (%) 13 (50) 17 (65)
Median lymph nodes removed (range) 25 (10 – 50) 23 (4 – 50)
Median lymph nodes involved (range) 1 (0 – 4) 2 (0 – 14)
Median ratio involved/removed (range) 4 (0 – 36) 7 (0 – 57)
Complete cytoreduction 19 (73) 14 (54)
Residual tumour (%)   
   ≤ 1 cm 2 (8) 4 (15)
   1.1 – 2 cm 1 (4) 2 (8)
   > 2 cm 4 (15) 6 (23)
Location of residual tumour* (%)   
   Pelvis 2 (15) 3 (19)
   Upper abdomen 6 (46) 6 (37.5)
   Peritoneal, extensive 4 (31) 6 (37.5)
   Retroperitoneal 1 (8) 1 (6)
  1. * Some patients had more than one location.